Stock Events

Stock Events

Bioporto AS 

$0.149000
26
-$0.00-0% Friday 21:00

Statistics

Day High
0.31
Day Low
0.31
52W High
0.31
52W Low
0.149
Volume
30,000
Avg. Volume
0
Mkt Cap
73.77M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
Next
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-201.5%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
6.25MRevenue
-12.59MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow THOXF. It's not an investment recommendation.
Novo Nordisk
9
NOVO-B.CO
Tryg AS
7
TRYG.CO
Vestas Wind Systems AS
5
VWS.CO
Danske Bank AS
5
DANSKE.CO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories competes with BioPorto in the diagnostics and medical devices sector, particularly in areas related to kidney health and diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers a range of products for the life science research and clinical diagnostics markets, overlapping with BioPorto's diagnostic solutions.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates in the diagnostics and research sector, directly competing with BioPorto in the development of diagnostic tests and products.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with BioPorto's offerings.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company competes in the medical technology sector, offering products for diagnostics, healthcare worker safety, and infection prevention that overlap with BioPorto's market.
Resmed
RMD
Mkt Cap34.67B
ResMed Inc. specializes in cloud-connectable medical devices for sleep apnea, COPD, and other chronic diseases, indirectly competing with BioPorto in the broader healthcare diagnostics market.
QuidelOrtho
QDEL
Mkt Cap1.01B
Quidel Corporation specializes in diagnostic healthcare solutions, including rapid diagnostic testing, competing directly with BioPorto's diagnostic products.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health operates in the precision oncology field, offering liquid biopsy tests that, while focused on cancer, compete in the broader diagnostics market against BioPorto's solutions.

About

BioPorto A/S is an in-vitro diagnostics firm that supplies diagnostic tools and antibodies globally to medical professionals and scientists. Its product portfolio includes the neutrophil gelatinase-associated lipocalin (NGAL) test – a particle-enhanced turbidimetric assay designed to quantify NGAL levels, which complements existing clinical assessments and standard diagnostic procedures. Furthermore, it supplies monoclonal antibodies for scientific, pharmaceutical, and clinical research applications, along with enzyme-linked immunosorbent assay (ELISA) kits, automated in-vitro diagnostic assays, and a versatile rapid assay device platform for developing lateral flow assays. BioPorto distributes its products through its proprietary sales force, an extensive network of distributors, and strategic OEM collaborations. Established in 2000, the company's base of operations is in Hellerup, Denmark.
Show more...
CEO
Carsten Buhl
Employees
46
Country
Denmark
ISIN
DK0011048619
WKN
000893191

Listings

OTC Link
US
THOXF
CO
DK
BIOPOR.CO
F
DE
2P4.F
LSE
GB
0JJM.LSE

0 Comments

Share your thoughts

FAQ

What is Bioporto AS stock price today?▼
The current price of THOXF is $0.15 USD — it has decreased by -0% in the past 24 hours. Watch Bioporto AS stock price performance more closely on the chart.
What is Bioporto AS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Bioporto AS stocks are traded under the ticker THOXF.
Is Bioporto AS stock price growing?▼
THOXF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Bioporto AS has showed a -48.26% decrease.
What is Bioporto AS market cap?▼
Today Bioporto AS has the market capitalization of 73.77M
When is the next Bioporto AS earnings date?▼
Bioporto AS is going to release the next earnings report on November 19, 2026.
What is Bioporto AS revenue for the last year?▼
Bioporto AS revenue for the last year amounts to 6.25M USD.
What is Bioporto AS net income for the last year?▼
THOXF net income for the last year is -12.59M USD.
How many employees does Bioporto AS have?▼
As of September 04, 2026, the company has 46 employees.
In which sector is Bioporto AS located?▼
Bioporto AS operates in the Health & Wellness sector.
When did Bioporto AS complete a stock split?▼
Bioporto AS has not had any recent stock splits.
Where is Bioporto AS headquartered?▼
Bioporto AS is headquartered in Hellerup, Denmark.